Africa: Biovac's Cholera Vaccine Test for Africa's Self-Reliance

Cape Town-based pharmaceutical firm Biovac is preparing to produce Africa's first end-to-end cholera vaccine, with a targeted market release by 2028. Vials of the vaccine have begun rolling off production conveyors at the facility, marking a concrete step in the continent's pharmaceutical manufacturing efforts.

This development represents a significant advancement for the broader continental initiative aimed at increasing local vaccine production. The effort shifts Africa's pharmaceutical landscape from long-term political ambition into active production, bolstering regional self-reliance in healthcare and vaccine supply chains.